A Pilot and Surgical Study of Larotrectinib for Treatment of Children With Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Latest Information Update: 28 Aug 2024
At a glance
- Drugs Larotrectinib (Primary)
- Indications Anaplastic astrocytoma; Diffuse intrinsic pontine glioma; Glioblastoma; Glioma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms CONNECT1903
- 20 Apr 2021 Status changed from not yet recruiting to recruiting.
- 02 Mar 2021 Planned initiation date changed from 1 Feb 2021 to 1 Apr 2021.
- 14 Dec 2020 Planned initiation date changed from 1 Dec 2020 to 1 Feb 2021.